Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis

[1]  Jin Choul Chai,et al.  The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line , 2021, Scientific Reports.

[2]  B. V. van Bon,et al.  Clinical delineation of SETBP1 haploinsufficiency disorder , 2021, European Journal of Human Genetics.

[3]  Da-Wei Zhang,et al.  Cloning, expression and enzyme activity delineation of two novel CANT1 mutations: the disappearance of dimerization may indicate the change of protein conformation and even function , 2020, Orphanet Journal of Rare Diseases.

[4]  F. C. Bennett,et al.  The influence of environment and origin on brain resident macrophages and implications for therapy , 2019, Nature Neuroscience.

[5]  Hong Liu,et al.  GDF‐15 promotes mitochondrial function and proliferation in neuronal HT22 cells , 2019, Journal of cellular biochemistry.

[6]  M. Lalowski,et al.  SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub , 2018, Nature Communications.

[7]  J. Qian,et al.  SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. , 2018, Pathology, research and practice.

[8]  Zhi-Xu He,et al.  Schinzel–Giedion syndrome: a novel case, review and revised diagnostic criteria , 2018, Journal of Genetics.

[9]  Delong Liu,et al.  SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome , 2017, Biomarker Research.

[10]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[11]  H. Makishima Somatic SETBP1 mutations in myeloid neoplasms , 2017, International Journal of Hematology.

[12]  L. Anelli,et al.  SETBP1 dysregulation in congenital disorders and myeloid neoplasms. , 2017, Oncotarget.

[13]  B. V. van Bon,et al.  Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies , 2017, PLoS genetics.

[14]  E. Audinat,et al.  Microglia in CNS development: Shaping the brain for the future , 2017, Progress in Neurobiology.

[15]  J. Maciejewski,et al.  Myb expression is critical for myeloid leukemia development induced by Setbp1 activation , 2016, Oncotarget.

[16]  Zev N. Kronenberg,et al.  Age-related mutations and chronic myelomonocytic leukemia , 2016, Leukemia.

[17]  M. Manière,et al.  Long term follow up of two independent patients with Schinzel-Giedion carrying SETBP1 mutations. , 2015, European journal of medical genetics.

[18]  Omar Abdel-Wahab,et al.  SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS , 2014, Leukemia.

[19]  S. Miyano,et al.  Somatic SETBP1 mutations in myeloid malignancies , 2013, Nature Genetics.

[20]  C Haferlach,et al.  SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations , 2013, Leukemia.

[21]  Roberta Spinelli,et al.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia , 2012, Nature Genetics.

[22]  Matteo Benelli,et al.  372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment. , 2012, European journal of medical genetics.

[23]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[24]  Nobuhiko Okamoto,et al.  Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel–Giedion syndrome , 2010, Journal of Medical Genetics.

[25]  Christian Gilissen,et al.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.

[26]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[27]  N. Kakazu,et al.  Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET. , 2001, European journal of biochemistry.

[28]  A. Schinzel,et al.  A syndrome of severe midface retraction, multiple skull anomalies, clubfeet, and cardiac and renal malformations in sibs. , 1978, American journal of medical genetics.